Non-Benzodiazepine Sedative Hypnotic Agents
Drugs: doxycycline delayed-release, Doryx (doxycycline hyclate delayed-release), Moxatag (extended-release amoxicillin). Drugs: Adderall (amphetamine, dextroamphetamine mixed salts), Adderall XR (amphetamine, dextroamphetamine mixed salts XR), amphetamine salt combo extended release, amphetamine salt combo immediate release, Concerta (methylphenidate), Daytrana (methylphenidate), Desoxyn (methamphetamine), Dexedrine Spansule (dextroamphetamine), dexmethylphenidate, dextroamphetamine, dextroamphetamine SR, Focalin (dexmethylphenidate), Focalin XR (dexmethylphenidate XR), Metadate CD (methylphenidate hydrochloride CD), Metadate ER (methylphenidate hydrochloride extended-release), methamphetamine, Methylin (methylphenidate), Methylin ER (methylphenidate ER), methylphenidate, methylphenidate ER/SA, Nuvigil (armodafinil), Procentra (dextroamphetamine), Provigil (modafinil), Ritalin (methylphenidate), Ritalin LA (methylphenidate LA), Ritalin SR (methylphenidate SR), Vyvanse (lisdexamfetamine). Drug Utilization Review of the following drugs/drug classes: to 4:30 p.m., Meeting Room 6, Concourse, Empire State Plaza, Albany, New York. The Drug Utilization Review (DUR) Board will meet on March 10, 2011, from 9:00 a.m. Medicaid Drug Utilization Review (DUR) Board Meeting Agenda for March 10, 2011 All Health Care Professionals & Patient Safety. 
Clinical Guidelines, Standards & Quality of Care. Health & Safety in the Home, Workplace & Outdoors. Birth, Death, Marriage & Divorce Records.
0 kommentar(er)
